相关实验视频
Updated: Jan 12, 2026

09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
27.7K
梅利-波普研究:地中海生活方式在儿童肥胖预防中. 一个随机对照试验的研究协议
Pilar De Miguel-Etayo1,2,3, Katherine Flores-Rojas4, Rocío Vázquez-Cobela1,5,6
1Centro de Investigación Biomédica en Red de Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
BMC public health
|November 5, 2025
概括
这项研究研究了地中海饮食和身体活动 (PA) 对肥胖风险儿童的干预措施. 预计早期的生活方式改变将减少儿童肥胖和相关的健康问题.
科学领域:
- 儿科 儿科 儿科
- 公共卫生 公共卫生
- 营养科学 营养科学
背景情况:
- 儿童肥胖是一个主要的公共卫生问题,特别是在地中海地区.
- 饮食和体育活动 (PA) 是影响肥胖风险的关键可修改因素.
- 地中海饮食和定期的PA被推广为保护策略.
研究的目的:
- 评估地中海饮食和PA干预措施在预防儿童肥胖方面的有效性.
- 为了比较干预和对照组之间的5年和10年的肥胖发病率.
- 评估早期生活方式干预措施对儿童健康的长期影响.
主要方法:
- 一个随机控制的多中心试验 (MELI-POP) 涉及310名3-6岁儿童,有肥胖风险.
- 干预组接受了关于地中海饮食和PA的教育,以及特定的食品规定和结构化的PA会议.
- 对照组接受了通常的护理;遵守情况受到监测.
- 主要结局:肥胖;次要结局:通过饮食摄入,PA,健身,生物标志物,遗传学和代谢学.
主要成果:
- 该研究正在进行中;主要和次要结果正在评估中.
- 数据收集包括脂肪,饮食习惯,身体活动水平,健身以及各种生物标志物.
- 纵向分析将确定干预措施对5年和10年的肥胖发病率的影响.
结论:
- 预防儿童肥胖对于减轻相关的并发症至关重要.
- 早期的生活方式干预有望带来长期的健康益处.
- 预计这些发现将为预防肥胖的公共卫生策略提供信息.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Drug Dosing: Obese Patients
208
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
208
Bioavailability Study Design: Healthy Subjects Versus Patients
137
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
137
Lifestyle Factors and Health
400
Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
400
Pharmacokinetics in Pediatric Patients: Drug Metabolism
182
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
182
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
230
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
230

